Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.0K
Overview
51.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rotavirus mucosal immunology: insights and research priorities from an international convening in Liverpool, March 2024.

NPJ vaccines·2026
Same author

The Maternal Vaccine Study Protocol: A Victorian Cohort Study Evaluating Infant and Childhood Safety and Health and Developmental Outcomes After Vaccination Against Respiratory Viruses in Pregnancy.

Vaccines·2026
Same author

Delayed diagnosis is associated with complications following invasive meningococcal disease in Australian adolescents and young adults.

Infection·2026
Same author

Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment.

Vaccine·2026
Same author

Characterizing thunderstorm asthma emergency department presentations using natural language processing for improved real-time surveillance.

American journal of epidemiology·2026
Same author

Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.

Vaccine·2026

Related Experiment Video

Updated: Dec 29, 2025

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.3K

Rotavirus vaccines--an update.

Carl D Kirkwood1, Jim Buttery

  • 1Department of Gastroenterology and Clinical Nutrition, Murdoch Childrens Research Institute, Royal Children's Hospital, Flemington Road, Parkville, Victoria, Australia, 3052. kirkwooc@cryptic.rch.unimelb.edu.au

Expert Opinion on Biological Therapy
|April 30, 2003
PubMed
Summary

Rotavirus vaccines are crucial for preventing severe gastroenteritis. Ongoing research and funding initiatives aim to ensure the safety and accessibility of these life-saving vaccines globally.

More Related Videos

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.2K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.8K

Related Experiment Videos

Last Updated: Dec 29, 2025

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.3K
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
10:49

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus

Published on: January 28, 2019

9.2K
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
09:13

Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy

Published on: November 1, 2011

17.8K

Area of Science:

  • Vaccinology
  • Infectious Diseases
  • Public Health

Background:

  • Rotavirus gastroenteritis poses a significant global health burden, particularly in developing nations.
  • The withdrawal of an early rotavirus vaccine due to intussusception (IS) concerns highlighted the critical need for rigorous safety evaluations.
  • Despite safety challenges, rotavirus vaccines remain the most effective tool for disease prevention.

Purpose of the Study:

  • To review the current landscape of rotavirus vaccine development.
  • To address the safety concerns and ongoing research into new vaccine candidates.
  • To explore strategies for enhancing vaccine accessibility, especially in resource-limited settings.

Main Methods:

  • Review of clinical trial data for rotavirus vaccine candidates.
  • Analysis of safety profiles, including associations with intussusception.
  • Examination of funding models and global health initiatives for vaccine deployment.

Main Results:

  • Several new rotavirus vaccine candidates are progressing through clinical trials (Phase I, II, and III).
  • A bovine-human reassortant vaccine and an attenuated human monovalent vaccine are in late-stage trials.
  • Innovative funding strategies are being developed to support vaccine production and distribution in developing countries.

Conclusions:

  • Rotavirus vaccine development continues with a focus on improved safety and efficacy.
  • Ensuring equitable access to rotavirus vaccines is essential for global public health.
  • Continued investment and international collaboration are vital for controlling rotavirus disease worldwide.